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Letters to the Editor09.42.18 in the International Pediatric
and Congenital Cardiac Code.4 This
variation appears in 45% of human
hearts.2,3
The double RCA is an extremely
uncommon coronary artery anomaly
with 2 RCAs, coursing toward the
right atrioventricular groove, originat-
ing marginal branches, terminating by
giving off the posterior descending ar-
tery in the posterior interventricular
groove. It is predominantly seen in
male patients and might originate
from either single or separate ostia.5
We think it is important to standard-
ize the nomenclature in order to have
the correct identification of anatomic
structures.
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To the Editor:
We read with great interest the arti-
cle ‘‘Aortic Valve Replacement: Re-
sults and Predictors of Mortality
From a Contemporary Series of 2256The JournalPatients,’’ by Di Eusanio and associ-
ates,1 in a recent issue of the Journal.
We congratulate Di Eusanio and asso-
ciates on their favorable results after
aortic valve replacement (AVR) in oc-
togenarians and on the identification
of predictors for postoperative mortal-
ity. Some methodologic issues exist,
however, concerning the comparison
of patient survivals with that of a refer-
ence population. The investigators
used a static method to compare the
3-year survival for octogenarians who
had undergone AVR with the expected
survival of an age- and sex-matched re-
gional population and concluded that
the survivals were statistically similar
(P ¼ .157).
Intuitively, it would seem apparent
that survival after AVR is unlikely to
be comparable to that of the general
population. Patients undergoing heart
valve replacement are vulnerable to
both valve-related and non–valve-re-
lated events. In addition, the left ven-
tricle in a patient with aortic valve
disease is characterized by progres-
sive accumulation of interstitial myo-
cardial fibrosis and impairment of
myocyte ultrastructure, leading to de-
creased survival. Aortic stenosis has
been shown to be an inflammatory
process associated with histopatho-
logic changes in the valve leaflets
that are similar to those seen in other
atherosclerotic diseases, and the pres-
ence of calcific valve disease is associ-
ated with hypertension, diabetes, and
the metabolic syndrome.2 A survival
comparable to that of the general pop-
ulation can therefore only be achieved
by strict selection of patients undergo-
ing AVR, which is the case in the
study by Di Eusanio and associates.1
The major shortcoming in the static
comparison method is that a dynamic
cohort, in this case the octogenarian
study population, is being compared
with a static reference cohort from
the regional life tables. Changes in
the patient group caused by with-
drawal at different times make the
study cohort dynamic and necessitate
a rate adjustment to make theof Thoracic and Cardiovascular Surgercomparison with the reference cohort
more accurate.3-5 Rate adjustment
can be achieved by matching the
reference cohort with respect to age,
sex, and calendar time at every
moment that an event occurs in the
study population. The benefit of
treatment is overestimated when this
mechanism is not taken into account.
It would be interesting if Di Eusanio
and associates were to compare the
survival of the patient group with
that of the age-, sex-, and calendar
time–matched regional population by
means of rate adjustment.
Matching should be performed not
only for age and sex but also for other
important demographic indicators,
such as ethnicity and socioeconomic
class.5 Unfortunately, these data are
seldom available, and consequently
comparisons with the general popula-
tion should be interpreted carefully.
Finally, we question some of the
numbers and the corresponding fig-
ures in the article. Figure 1 in the
article shows a significantly lower sur-
vival of patients in New York Heart
Association functional class III or IV
than of those in class I or II (P <
.001), whereas in the text a nonsignifi-
cant P value of .157 is stated. In addi-
tion, Figure 3 in the article shows
a 2-year survival of 87.4% for the
AVR after 80 years of age group,
whereas in the text a 2-year survival
of 89.7% is mentioned.
In our opinion, comparison with
a reference group should be handled
with caution. We suggest the develop-
ment of specific guidelines to compare
an accurately matched population to
ensure that all factors are taken into
account and that the comparison per-
formed is methodologically correct.
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doi:10.1016/j.jtcvs.2011.07.063Reply to the Editor:
We thank Osnabrugge and col-
leagues for their interest in our article
and appreciate their comments on the
statistical methodology that we adop-
ted for the comparison between the
survival of elderly patients undergo-
ing aortic valve replacement (AVR)
and the expected survival of the age-
and sex-matched general population.
We acknowledge that the method
suggested by Osnabrugge and col-
leagues should be applied in studies
with extended long-term follow-up, be-
cause of a strong correlation between
age and length of follow-up, to avoid
underestimation of the general popula-
tion survival. This statistical method is
validated for long-term follow-up, but
it is needed less1 for studies with short
follow-up, such as our own, in which it
is possible to assume thatwithdrawal at
different times does not affect the esti-
mates of survival. As a matter of fact, it
is not surprising that, among many,1290 The Journal of Thoracic andsuch authoritative Institutions as The
Cleveland Clinic,2 the New York State
Department of Health’s Cardiac Sur-
gery Reporting System,3 and others4
have recently used the same methodol-
ogy as we to compare the dynamic sur-
vival of a surgical population with the
static expected survival of a corre-
sponding age- and sex-matched gen-
eral population.
Moreover, we do not find it intui-
tively apparent that survival after
AVR is unlikely to be comparable to
that of the general population unless
there is a strict selection of patients,
as speculated by Osnabrugge and col-
leagues when referring to our study
cohort. We note that (1) a surgical
population is selected by definition
(see the limitations of our study listed
in the article), (2) progressive accu-
mulation of interstitial myocardial fi-
brosis may be present in elderly
subjects with or without aortic valve
stenosis, and (3) we reported the pre-
operative characteristics of our pa-
tients, and our findings are consistent
with much growing and converging
evidence indicating that long-term
survival of octogenarian patients can
be equal to the expected survival of
an age- and gender-matched popula-
tion, which should not be neglected
by Osnabrugge and colleagues.2,4,5
Any attempt to explain such a favor-
able outcome after AVR in the elderly
population can only be speculative
and thus will not be the subject of dis-
cussion here. It may, however, have
something to do with a lower cumula-
tive incidence of tissue valve–related
complications in elderly patients
with limited life spans, with a higher
incidence of cardiac events among
people with severe aortic valve steno-Cardiovascular Surgery c November 20sis who do not undergo AVR, and with
the exclusion—as in our series—of
patients undergoing associated myo-
cardial revascularization and/or redo
operations.
We apologize for the mentioned
errors of transcription from figures to
text. A significant (P<.001) survival
difference was observed between pa-
tients operated on in New York Heart
Association functional class III or IV
and those operated on in functional
class I or II. In addition, the 2-year
survival for the group undergoing
AVR after the age of 80 years group
was in fact 87.4%.
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